Soluble guanylate cyclase activator vericiguat prevents anthracycline-mediated cardiotoxicity and sarcopenia through NO-sGC-cGMP-NLRP3 pathway
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
4 More presentations in this session
Doctor M. Ho (Hong Kong, HK)
Doctor M. Laufer-Perl (Tel Aviv, IL)
Doctor R. Lorca (Oviedo, ES)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
